Ebos Group (Ebos Group) Equity-to-Asset : 0.34 (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Ebos Group Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Ebos Group's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $1,585 Mil. Ebos Group's Total Assets for the quarter that ended in Dec. 2023 was $4,647 Mil. Therefore, Ebos Group's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.34.

The historical rank and industry rank for Ebos Group's Equity-to-Asset or its related term are showing as below:

EBOSF' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.33 Med: 0.36 Max: 0.45
Current: 0.34

During the past 13 years, the highest Equity to Asset Ratio of Ebos Group was 0.45. The lowest was 0.33. And the median was 0.36.

EBOSF's Equity-to-Asset is ranked worse than
56% of 100 companies
in the Medical Distribution industry
Industry Median: 0.385 vs EBOSF: 0.34

Ebos Group Equity-to-Asset Historical Data

The historical data trend for Ebos Group's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ebos Group Equity-to-Asset Chart

Ebos Group Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Equity-to-Asset

Get a 7-Day Free Trial

0.39

0.35

0.36

0.38

Ebos Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Equity-to-Asset	Get a 7-Day Free Trial															0.45	0.36	0.37	0.38	0.34

Competitive Comparison of Ebos Group's Equity-to-Asset

For the Medical Distribution subindustry, Ebos Group's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ebos Group's Equity-to-Asset Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Ebos Group's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Ebos Group's Equity-to-Asset falls into.

Ebos Group Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Ebos Group's Equity to Asset Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Equity to Asset (A: Jun. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	1625.304	/	4297.639
	=	0.38

Ebos Group's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	1584.826	/	4647.295
	=	0.34

Ebos Group (OTCPK:EBOSF) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Ebos Group Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Ebos Group's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Ebos Group (Ebos Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Ebos Group Ltd (OTCPK:EBOSF) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

EBO:New Zealand EJG:Germany EBO:Australia

Address

108 Wrights Road, P.O. Box 411, Christchurch, STL, NZL, 8024

Website

https://www.ebosgroup.com

Ebos is the largest pharmaceutical wholesaler and distributor across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 60% and 30% of revenue respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low single digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.

Ebos Group (Ebos Group) Headlines

From GuruFocus

Half Year 2024 EBOS Group Ltd Earnings Call Transcript

By GuruFocus Research • 02-28-2024